A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.

NCT00377234 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

356

Enrollment

INDUSTRY

Sponsor class

Conditions

Post Menopausal Osteoporosis

Interventions

DRUG: Risedronate
DRUG: ibandronate [Bonviva/Boniva]

Sponsor

Hoffmann-La Roche